Schedule 13G ownership disclosure
Century Therapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 15673T100
Event date: 2026-01-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 13,486,400.00 · Class: 7.34%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 10,609,008.00 · Class: 5.78%
- David Kroin
Shares: 13,486,400.00 · Class: 7.34%
- Deep Track Special Opportunities Fund, LP.
Shares: 2,877,392.00 · Class: 1.57%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-26-000198
- Form type
- SCHEDULE 13G
- Filer
- Century Therapeutics, Inc.
- CIK
- CIK 1850119
- Filed
- Jan 15, 2026
- Reporting period
- Jan 08, 2026
- Description
- Schedule 13G beneficial ownership